Ascendis Pharma A/S (ASND)
NASDAQ: ASND · IEX Real-Time Price · USD
135.21
-1.31 (-0.96%)
At close: Jul 19, 2024, 4:00 PM
135.26
+0.05 (0.04%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $7.65 billion as of July 22, 2024. Its market cap has increased by 54.03% in one year.
Market Cap
7.65B
Enterprise Value
8.03B
1-Year Change
54.03%
Ranking
Category
Stock Price
$135.21
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $7.65B, an increase of 1,605.62%. That is a compound annual growth rate of 34.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 7.87B | 8.41% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
| Jan 28, 2015 | 448.80M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roivant Sciences | 8.13B |
| Lantheus Holdings | 8.10B |
| Intra-Cellular Therapies | 7.90B |
| Cerevel Therapeutics Holdings | 7.82B |
| The Ensign Group | 7.71B |
| Revolution Medicines | 7.61B |
| Penumbra | 7.36B |
| Blueprint Medicines | 7.20B |